• Entered into a licensing agreement with Cerveau Technologies, Inc. for the rights to a Tau protein tracer in China.
• Entered into a licensing agreement with Piramal Imaging SA for the rights to beta amyloid tracer Neuraceq^TM in China.
• Closed a CNY ¥150m series B financing round co-invested by Qiming Venture Partners and 3E Bioventures.